BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38611084)

  • 1. Bilateral Thoracic Cytoreductive Surgery for Pseudomyxoma Peritonei of Appendiceal Origin.
    Mehta S; Kammar P; Sukumar V; Pandey J; Garach N; Bhorkar N; Bhatt A
    Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):161-165. PubMed ID: 37359933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines.
    Lin YL; Xu DZ; Li XB; Yan FC; Xu HB; Peng Z; Li Y
    Orphanet J Rare Dis; 2021 Feb; 16(1):85. PubMed ID: 33581733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in Biological Research and Treatment of Pseudomyxoma Peritonei.
    Li X; Liu G; Wu W
    Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours.
    Lansom J; Alzahrani N; Liauw W; Morris DL
    Indian J Surg Oncol; 2016 Jun; 7(2):166-76. PubMed ID: 27065707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study.
    Di Leo A; Corvasce A; Weindelmayer J; Mason EJ; Casella F; de Manzoni G
    Updates Surg; 2020 Dec; 72(4):1207-1212. PubMed ID: 32410159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of pseudomyxoma peritonei arising from a perforated intraductal papillary mucinous neoplasm that underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Yoshizaki Y; Gohda Y; Inagaki F; Kataoka A; Takemura N; Miyazaki H; Igari T; Kiyomatsu T; Yano H; Kokudo N
    Clin J Gastroenterol; 2024 Feb; 17(1):188-197. PubMed ID: 37980306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approach to pseudomyxoma peritonei.
    Rizvi SA; Syed W; Shergill R
    World J Gastrointest Surg; 2018 Aug; 10(5):49-56. PubMed ID: 30190782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of pseudomyxoma peritonei (PMP) through cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC): A case report and literature review.
    Awad A; Awad M; Alami M; Sablan AA; Shrateh ON; Jubran F
    Int J Surg Case Rep; 2024 Jun; 119():109656. PubMed ID: 38677258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterization of NCC-PMP2-C1: a novel patient-derived cell line of pseudomyxoma peritonei with signet ring cells.
    Noguchi R; Yoshimatsu Y; Sin Y; Ono T; Tsuchiya R; Yoshida H; Kiyono T; Yonemura Y; Kondo T
    Hum Cell; 2024 Mar; 37(2):511-522. PubMed ID: 38143259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of a small-molecule inhibitor of KRAS
    Vázquez-Borrego MC; Granados-Rodríguez M; Bura FI; Martínez-López A; Rufián-Andújar B; Valenzuela-Molina F; Rodríguez-Ortiz L; Haro-Yuste S; Moreno-Serrano A; Ortega-Salas R; Pineda-Reyes R; Michán C; Alhama J; Romero-Ruiz A; Arjona-Sánchez Á
    Exp Hematol Oncol; 2023 Dec; 12(1):102. PubMed ID: 38066554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A2AR Expression and Immunosuppressive Environment Independent of
    Kusamura S; Busico A; Conca E; Capone I; Agnelli L; Lorenzini D; Brich S; Angelini M; Volpi CC; Trupia DV; Lagano V; Torelli T; Gloghini A; Baratti D; Guaglio M; Milione M; Deraco M; Perrone F
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal BromAc
    Mekkawy AH; Breakeit M; Pillai K; Badar S; Akhter J; Valle SJ; Morris DL
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Under the Hood: Understanding the Features of Mucin in Pseudomyxoma Peritonei.
    Villarejo-Campos P; García-Arranz M; Qian S; Jiménez de Los Galanes S; Domínguez-Prieto V; Vélez-Pinto JF; Guijo Castellano I; Jiménez-Fuertes M; Guadalajara H; García-Olmo D
    J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373701
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.